Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosis is a research paper published in PLoS ONE (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Division of Cancer Epidemiology and Genetics, National Cancer Institute
Grant: U54CA233396, U54CA233444, & U54CA233465
National Cancer Coalition
Grant: SC1CA190505
National Institute on Minority Health and Health Disparities
Grant: U54 MD007582